The MRI perfusion scan appears to be used to monitor ongoing therapy rather than surveillance for GBM. proven study for surveillance after GBM. Treatment evaluation of patients with glioblastomas is important to aid in clinical decisions. Conventional MRI with contrast is currently the standard method, but unable to differentiate tumor progression from psuedoprogression, and perfusion MRI can do so by using additional measurable parameters. Its use is supported by the belwo references guidelines.
van Dijken BRJ, van Laar PJ, Smits M, Dankbaar JW, Enting RH, van der Hoorn A. Perfusion MRI in treatment evaluation of glioblastomas: Clinical relevance of current and future techniques. J Magn Reson Imaging. 2019 Jan;49(1):11-22.
Richard E. Latchaw, Howard Yonas, George J. Hunter, William T.C. Yuh, Toshihiro Ueda, A. Gregory Sorensen, Jeffrey L. Sunshine, Jose Biller, Lawrence Wechsler, Randall Higashida and George Hademenos, A Scientific Statement for Healthcare Professionals by the Writing Group on Perfusion Imaging, From the Council on Cardiovascular Radiology of the American Heart Association, Stroke. 2003;34:1084–1104
Revised 2022 (Resolution 24)* ACR–ASNR–SPR PRACTICE PARAMETER FOR THE PERFORMANCE OF INTRACRANIAL MAGNETIC RESONANCE PERFUSION IMAGING 2022